Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 2/3 1Phase 2 1Phase 1 1

Status

Completed 18Recruiting 11Unknown 6Not yet recruiting 6Terminated 2Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 120Neoplasms 75Prostatic Neoplasms 70Lung Neoplasms 36Carcinoma, Non-Small-Cell Lung 33Pancreatic Neoplasms 32Colorectal Neoplasms 32Head and Neck Neoplasms 29Carcinoma, Hepatocellular 24Brain Neoplasms 24Colonic Neoplasms 22Motor Activity 19Carcinoma, Renal Cell 18Pain 16Ovarian Neoplasms 16Neoplasm Metastasis 14Hematologic Neoplasms 14Urinary Bladder Neoplasms 13Rectal Neoplasms 13Lymphoma, Follicular 13Fatigue 13Sarcoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Glioblastoma 12Lymphoma 11Liver Neoplasms 11Glioma 11Squamous Cell Carcinoma of Head and Neck 10Leukemia 10Anxiety Disorders 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Withdrawn × Myasthenia Gravis × Clear all
NCT03900585 2021-03-10

Can Interval Walking Influence on Fatigue in the Danish Cohort of Myasthenia Gravis Patients

Rigshospitalet, Denmark

Phase NA Withdrawn

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡